103
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting

, , , &
Pages 683-692 | Accepted 16 Feb 2006, Published online: 07 Mar 2006

References

  • Lloyd-Jones D, Wang T, Leip E, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042–6
  • Feinberg W, Blackshear J, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469–73
  • Chatap G, Giraud K, Vincent J. Atrial fibrillation in the elderly: facts and management. Drugs Aging 2002;19:819–46
  • Aguilar M, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2005, Issue 3. Art. No.: CD001927 [DOI: 10.1002/14651858.CD001927.pub2]
  • Hylek E, Skates S, Sheehan M, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. New Engl J Med 1996;335:540–6
  • ECB/EU. ECU/EUR exchange rates versus national currencies: Eurostat 2.11.2005
  • Menzin J, Boulanger L, Hauch O, et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed care study. Ann Pharmacother 2005;39:446–51
  • Anderson R. Cost analysis of a managed care decentralized outpatient pharmacy anticoagulation service. J Manag Care Pharm 2004;10:159–65
  • Stewart S, Murphy N, Walker A, et al. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004;90:286–92
  • Abdelhafiz AH, Wheeldon NM. Use of resources and cost implications of stroke prophylaxis with warfarin for patients with nonvalvular atrial fibrillation. Am J Geriatr Pharmacother 2003;1:53–60
  • Hujanen T. Terveydenhuollon yksikkökustannukset Suomessa vuonna 2001. Stakes Aiheita 2003(1)
  • Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? Br Med J 2000;320:1197–200
  • Barber JA, Thomson SG. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004;9:197–204
  • Burnham KP, Anderson DR. Multimodel inference, understanding AIC and BIC in model selection. Sociol Methods Res 2004;33:261–304
  • Stata base reference manual, vol. 2, K-Q, release 9. College Station (TX): Stata Press; 2005
  • Stata statistical software: release 9 [program]. College Station (TX): StataCorp LP; 2005
  • Duan N. Smearing estimate: a nonparametric retransformation method. J Am Statistical Assoc 1983;78:605–10
  • Efron B. Better bootstrap confidence intervals. J Am Statistical Assoc 1987;82:171–85
  • Drummond M, McGuire A. Statistical considerations in analysing health care resource utilization and cost data. Economic evaluation in health care, merging theory with practice. Oxford: Oxford University Press; 2001
  • Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461–94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.